Cite
HARVARD Citation
Li, R. et al. (2023). Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma. Blood science. 5 (2), pp. 118-124. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, R. et al. (2023). Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma. Blood science. 5 (2), pp. 118-124. [Online].